Brazil and USA at loggerheads over production of generic antiretrovirals.
作者信息
Ahmad K
出版信息
Lancet. 2001 Feb 10;357(9254):453. doi: 10.1016/S0140-6736(05)71270-8.
Abstract
摘要
相似文献
1
Brazil and USA at loggerheads over production of generic antiretrovirals.
Lancet. 2001 Feb 10;357(9254):453. doi: 10.1016/S0140-6736(05)71270-8.
2
AIDS drugs. Brazil, Thailand override big pharma patents.艾滋病药物。巴西、泰国无视大型制药公司的专利。
Science. 2007 May 11;316(5826):816. doi: 10.1126/science.316.5826.816.
3
. . . and Brazilian AIDS programme threatened by US trade action.……以及巴西艾滋病防治项目受到美国贸易行动的威胁。
Int J Epidemiol. 2001 Apr;30(2):413.
4
Global trade and access to medicines: AIDS treatments in Thailand.
Lancet. 1999 Nov 27;354(9193):1893-5. doi: 10.1016/S0140-6736(99)06114-0.
5
Lowering the cost of prescription drugs.降低处方药成本。
J La State Med Soc. 2003 Jan-Feb;155(1):51.
6
TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.《与贸易有关的知识产权协定》、药品专利与基本药物的获取：从西雅图到多哈的漫长之路
Chic J Int Law. 2002 Spring;3(1):27-46.
7
US concedes on cheaper drug production in Brazil.美国在巴西廉价药品生产问题上作出让步。
BMJ. 2001 Jul 7;323(7303):12.
8
Canada to change patent law to allow export of cheap drugs.加拿大将修改专利法以允许廉价药物出口。
Lancet. 2003 Oct 18;362(9392):1290. doi: 10.1016/S0140-6736(03)14620-X.
9
Production of low cost AIDS drugs to continue in Brazil.巴西将继续生产低成本艾滋病药物。
Reprod Health Matters. 2001 Nov;9(18):178.
10
Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.专利绊脚：艾滋病、治疗可及性与制造稀缺
Conn J Int Law. 2002 Spring;17(2):157-248.
引用本文的文献
1
Community health advocacy.社区健康倡导。
J Epidemiol Community Health. 2006 Jun;60(6):458-63. doi: 10.1136/jech.2004.023044.
Zotero 插件